With US now in hand, BioNTech CEO looks for more vaccine production

The chief executive of Germany's BioNTech SE said the biggest challenge facing it and partner Pfizer Inc now that their COVID-19 vaccine is authorised for use in the United States will be to scale up manufacturing to meet huge demand.

from bdnews24.com - Home https://ift.tt/3oM8Ocx